Spruce Biosciences, Inc.
SPRB
Price:
$0.535
Market Cap:
$22.10M
Spruce Biosciences, Inc., a biopharmaceutical company, focuses on developing and commercializing novel therapies for rare endocrine disorders. The company engages in developing tildacerfont, a non-steroidal therapy to enhance disease control and reduce steroid burden for adult patients suffering from congenital adrenal hyperplasia (CAH), which is in Phase 2b clinical trial; and to evaluate glucocorticoid reduction and clinical consequences in adult patients with classic CAH that is Phase 2b clinical trial. It is also developing tildacerfont for the treatment of pediatric classic congenital adrenal hyperplasia in children that is in Phase 2 clinical trial; and for females with polycystic ovar...[Read more]
Industry
Biotechnology
IPO Date
2020-10-09
Stock Exchange
NASDAQ
Ticker
SPRB
PE Ratio
[-0.51]
ROE
[-59.94%]
Current Ratio
[5.17]
Dividend Yield
[0%]
Enterprise Value
[-43894109.00]
Dividend History
The ROE as of November 2024 (TTM) for Spruce Biosciences, Inc. (SPRB) is -59.94%
According to Spruce Biosciences, Inc.’s latest financial reports and current stock price. The company's current ROE is -59.94%. This represents a change of 296.70% compared to the average of -15.11% of the last 4 quarters.
Spruce Biosciences, Inc. (SPRB) Historical ROE (quarterly & annually)
How has SPRB ROE performed in the past?
The mean historical ROE of Spruce Biosciences, Inc. over the last ten years is -14.72%. The current -59.94% ROE has changed 307.33% with respect to the historical average. Over the past ten years (40 quarters), SPRB's ROE was at its highest in in the March 2020 quarter at 183.00%. The ROE was at its lowest in in the March 2019 quarter at -177.66%.
Average
-14.72%
Median
-29.21%
Minimum
-65.82%
Maximum
55.38%
Spruce Biosciences, Inc. (SPRB) ROE by Quarter and Year
Discovering the peaks and valleys of Spruce Biosciences, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 90.75%
Maximum Annual ROE = 55.38%
Minimum Annual Increase = -146.51%
Minimum Annual ROE = -65.82%
| Year | ROE | Change |
|---|---|---|
| 2023 | -62.63% | -4.84% |
| 2022 | -65.82% | 71.72% |
| 2021 | -38.33% | 90.75% |
| 2020 | -20.09% | -146.51% |
| 2019 | 43.21% | -21.98% |
Spruce Biosciences, Inc. (SPRB) Average ROE
How has SPRB ROE performed in the past?
The current ROE of Spruce Biosciences, Inc. (SPRB) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-55.59%
5-year avg
-28.73%
10-year avg
-14.72%
Spruce Biosciences, Inc. (SPRB) ROE vs. Peers
How is SPRB’s ROE compared to its peers?
Spruce Biosciences, Inc.’s ROE is greater than Inozyme Pharma, Inc. (-68.93%), greater than Day One Biopharmaceuticals, Inc. (-22.40%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Eledon Pharmaceuticals, Inc. (-124.74%), greater than HOOKIPA Pharma Inc. (-51.77%), less than X4 Pharmaceuticals, Inc. (32.93%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), greater than VectivBio Holding AG (-56.92%),
| Company | ROE | Market cap |
|---|---|---|
| -68.93% | $277.29M | |
| -22.40% | $1.49B | |
| -39.58% | $599.50M | |
| -124.74% | $280.20M | |
| -51.77% | $45.33M | |
| 32.93% | $89.59M | |
| -24.63% | $177.24M | |
| -56.92% | $1.06B |
Build a custom stock screener for Spruce Biosciences, Inc. (SPRB) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Spruce Biosciences, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Spruce Biosciences, Inc. (SPRB) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Spruce Biosciences, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Spruce Biosciences, Inc.'s ROE?
How is the ROE calculated for Spruce Biosciences, Inc. (SPRB)?
What is the highest ROE for Spruce Biosciences, Inc. (SPRB)?
What is the 3-year average ROE for Spruce Biosciences, Inc. (SPRB)?
What is the 5-year average ROE for Spruce Biosciences, Inc. (SPRB)?
How does the current ROE for Spruce Biosciences, Inc. (SPRB) compare to its historical average?